Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Catalent Pharma Solutions
WARNING LETTER
•Catalent Pharma Solutions•November 15, 2007

Catalent Pharma Solutions – FDA Warning Letter, Nov 15, 2007

Record Details

An FDA inspection of Catalent Pharma Solutions (Raleigh, NC) from November 6-15, 2007, revealed significant deviations from current Good Manufacturing Practice (CGMP) in the manufacture of [redacted], violating Section 501(a)(2)(B) of the FD&C Act and 21 CFR Parts 210 and 211.

Key violations include: 1. **Inadequate Quality Control Unit Investigations (21 CFR 211.192):** Failure to thoroughly investigate discrepancies, identify trends for environmental excursions (July-November 2007), and ensure timely completion of corrective actions (e.g., purified water loop heat exchanger not ordered, microbial identification delays). 2. **Insufficient Aseptic Processing Controls (21 CFR 211.42(c)(10)(v)):** Delayed systematic facility cleaning for mold despite prolonged environmental excursions, and lack of disinfectant effectiveness studies against representative microorganisms. 3. **Failure to Follow Sterile Product Procedures (21 CFR 211.113(b)):** Incomplete monitoring of Water for Injection use points, unreviewed environmental monitoring data by the quality unit, and failure to notify personnel of environmental monitoring excursions. 4. **Unvalidated Test Methods (21 CFR 211.165(e)):** Sterility test method STR-MTM

Company
Catalent Pharma Solutions
Inspection date
November 15, 2007
Office
Office of Compliance and Enforcement
Person
  • David K. Elder (Principal)
View Company Profile

ID · 17cecc8f-9cf8-4ad7-b848-5430ce460ccf

Violation Codes9
FD&C Act 501(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.19221 CFR 211.42(c)(10)(v)21 CFR 211.113(b)21 CFR 211.165(e)21 CFR 211.160(a)21 CFR 211.160(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Catalent Pharma Solutions
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.